3rd Circ. Says Cash Not Key For Pay-For-Delay Suits
A three-judge panel overturned the dismissal of an antitrust suit by Louisiana Wholesale Drug Co. Inc. and King Drug Co. of Florence Inc. challenging a Hatch-Waxman Act settlement GlaxoSmithKline PLC signed with Teva Pharmaceutical Industries Ltd.
The plaintiffs maintained that GSK paid off Teva to delay launching...
To view the full article, register now.